The Use of Calcimimetics for the Treatment of Secondary Hyperparathyroidism: A 10 Year Evidence Review

Seminars in Dialysis
Mariano RodriguezJohn Cunningham

Abstract

Until the discovery of calcimimetics, the management of secondary hyperparathyroidism (SHPT) relied exclusively on treatment with phosphate binders, vitamin D derivatives or surgical parathyroidectomy with limited success. The therapeutic use of calcimimetic agents, together with a better understanding of the pivotal role of the calcium-sensing receptor (CaSR) in the physiological regulation of parathyroid gland function, substantially advanced the management of hyperparathyroidism in dialysis practice. Calcimimetics bind selectively to the CaSR receptor in parathyroid tissue and enhance the inhibitory effect of extracellular calcium ions on parathyroid hormone (PTH) secretion, thereby reducing PTH levels even when serum calcium concentrations are normal or low. The availability of calcimimetic agents for clinical use has opened a new era in the management of patients with SHPT. Indeed, calcimimetic compounds have been shown to reduce PTH levels and to lower serum calcium concentrations in all forms of hyperparathyroidism, including primary hyperparathyroidism (PHPT) and parathyroid carcinoma. Such findings underscore the critical importance of the CaSR as a therapeutic target in this family of clinical disorders. New calcimime...Continue Reading

References

Aug 1, 1991·Endocrine Reviews·S L PocotteL A Fitzpatrick
Nov 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F MericM J Bia
Aug 1, 1983·The Journal of General Physiology·J López-Barneo, C M Armstrong
Feb 14, 1998·Kidney International·M WadaN Nagano
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·E F NemethM F Balandrin
Apr 29, 1998·The Journal of Clinical Endocrinology and Metabolism·M T CollinsS J Marx
Apr 9, 1999·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A J BleyerE Slatopolsky
Jun 2, 2000·The Journal of Membrane Biology·K WonnebergerP Wangemann
Aug 30, 2002·Journal of Molecular Endocrinology·E F Nemeth
Nov 22, 2002·Journal of the American Society of Nephrology : JASN·Bartolomé GarfiaMariano Rodríguez
Nov 1, 2003·The Journal of Pharmacology and Experimental Therapeutics·Edward F NemethDavid Martin
Apr 9, 2004·The New England Journal of Medicine·Geoffrey A BlockWilliam G Goodman
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Oct 28, 2004·American Journal of Physiology. Renal Physiology·Mariano RodriguezDavid Martin
Dec 23, 2004·The Journal of Clinical Endocrinology and Metabolism·Mark J BollandIan R Reid
Jun 9, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Andreas L SerraRudolf P Wüthrich
Jun 9, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anja E KruseMarkus G Mohaupt
Jun 29, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Chaim CharytanVincent Pichette
Feb 10, 2006·Journal of the American Society of Nephrology : JASN·Ignacio LopezMariano Rodriguez
Aug 22, 2006·Biochemical and Biophysical Research Communications·Sanela SmajilovicJacob Tfelt-Hansen
Jan 4, 2007·American Journal of Physiology. Renal Physiology·M E RodriguezM Rodriguez
Jun 1, 2007·American Journal of Physiology. Renal Physiology·Guerman MolostvovDaniel Zehnder
Aug 2, 2007·The Journal of Clinical Endocrinology and Metabolism·S J SilverbergJ P Bilezikian
Jul 18, 2008·Journal of the American Society of Nephrology : JASN·Casimiro VallePedro Aljama
Sep 18, 2008·American Journal of Nephrology·Takashi ShigematsuUNKNOWN KRN1493 Study Group
Nov 27, 2008·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Yoshihiro TominagaTetsuhiko Sato
Dec 19, 2008·American Journal of Physiology. Renal Physiology·Francisco J MendozaMariano Rodriguez
Dec 19, 2008·Kidney International·Nadezda KoleganovaMarie-Luise Gross
Dec 27, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michel ChoncholGeoffrey A Block
Jan 27, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kamyar Kalantar-Zadeh, Csaba P Kovesdy
Apr 10, 2009·Current Pharmaceutical Biotechnology·Sarah C Brennan, Arthur D Conigrave
Apr 17, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Pablo UreñaDenis Fouque
May 25, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Uri S Alon, René G VandeVoorde
Dec 15, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paolo RaggiUNKNOWN ADVANCE Study Group
Dec 17, 2010·Calcified Tissue International·Francisco J MendozaEscolastico Aguilera-Tejero
Jan 18, 2011·The Journal of Pharmacology and Experimental Therapeutics·Jian-Nong MaEthan S Burstein
Mar 23, 2011·The Journal of Pharmacology and Experimental Therapeutics·Charles HenleyJeff D Reagan

❮ Previous
Next ❯

Citations

Dec 3, 2016·Drugs·Hannah A Blair
Apr 6, 2017·Reviews in Endocrine & Metabolic Disorders·Mariano Rodríguez Portillo, María E Rodríguez-Ortiz
Dec 26, 2017·Hospital Pharmacy·Danial E Baker
Jun 24, 2020·International Journal of Molecular Sciences·Tally Naveh-Many, Oded Volovelsky
Nov 5, 2021·Journal of the American Society of Nephrology : JASN·William G GoodmanEdward F Nemeth

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Investigational Drugs
Linda J Krebs
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Anja E KruseMarkus G Mohaupt
Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
Manuel Muñoz Torres, Antonia García Martín
Advances in Renal Replacement Therapy
William G Goodman, Stewart A Turner
© 2022 Meta ULC. All rights reserved